Li-ting Niu
Beijing Key Laboratory Of Hematopoietic Stem Cell Transplantation
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bone marrow accumulation of perfluoroalkyl substances (PFASs) predicts post-transplant relapse in acute myeloid leukemia patients and associated with T-cell dysregulation.
Journal: Ecotoxicology and environmental safety
Published: September 08, 2025
RMRP-Induced Chemo-Resistance in Relapsed and Refractory Acute Myeloid Leukemia via Mitochondrial Dysfunction.
Journal: Cancer research and treatment
Published: March 11, 2025
RGS1 is an effective T-cell marker of acute myeloid leukemia remission after hematopoietic stem cell transplantation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 02, 2024
Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification.
Journal: Frontiers in oncology
Published: May 18, 2022
Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage.
Journal: Translational oncology
Published: June 13, 2021
TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026